Abstract
BACKGROUND People with peripheral neuropathies may experience significant sensorimotor impairment. Prescribed treatment includes wearing an orthosis. However, a common barrier to treatment effectiveness is patient adherence. Given the limited information available, it is essential to gather evidence on treatment adherence challenges.
OBJECTIVE This study aims to identify aspects that influence adherence to orthotic treatment in patients with peripheral neuropathies.
METHODS We applied a survey that included evaluation items from the Quest 2.0 to assess importance and satisfaction and self-developed questions. We conducted the assessment following the principles of Kano’s model to understand the nature of the aspects influencing adherence and prioritize opportunities for product improvement.
RESULTS Satisfaction with ease of adjustment, weight, ease of use, effectiveness, and dimensions, as well as perceived interference with daily activities, influences adherence to treatment. We found no correlation between orthosis appearance and adherence. However, it is a basic quality attribute and should be considered a relevant design requirement to avoid product rejection.
CONCLUSIONS We found differences between the estimate of importance obtained by explicit and inexplicit queries. Thus, cross-checking information from different query methods could minimize potential biases and accurately assess users’ perceptions of rehabilitation products.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
Funding (EBO): PhD. supported by the academic training program of the Universidad del Norte and the Colombian Ministry of Science grant: "Formación de capital humano de alto nivel para las regiones- Atlántico 2018".
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Comité de Ética de la Investigación con medicamentos del Hospital Universitario y Politécnico La Fe (CEIm La Fe). Registration number 2020-035-1
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
All data produced in the present work are contained in the manuscript
